CTHRC1 and fibrosis: Moreover, the discovery of proliferating Cthrc1+ fibrotic fibroblasts in other datasets of fibrosis in the skin, colon, liver, and heart (66–68) suggests that the therapeutic potential of selective targeting of proliferating fibroblasts may be broadly applicable to other fibrotic diseases.